Recent Finacing
Recent Raise
Teon Therapeutics is a San Francisco-based clinical-stage biopharmaceutical company developing small-molecule A2B receptor antagonists, including lead candidate TT-702 advancing into Phase 1b, to inhibit immunosuppressive tumor-microenvironment signaling.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
